Awata T, Sogo S, Yamamoto Y
Jpn J Ophthalmol. 1986;30(3):245-50.
A study was made of inhibitory effects of an aldose reductase inhibitor, CT-112 (5-(3-ethoxy-4-pentyloxyphenyl)-2,4-thiazolidinedione) ophthalmic solution, on the accumulation of sugar alcohol (dulcitol) in the corneal epithelium of rats fed on a 50% galactose diet. The effects were correlated with the concentrations of the drug solution. The rats were divided into 6 groups. One group was fed on a regular laboratory chow and was untreated. The other 5 groups were fed on a 50% galactose diet, and 0.1, 0.25, 0.5 or 1.0% CT-112 ophthalmic solution or its vehicle was instilled in both eyes 4 times a day in each of the 5 treated groups. After 2 weeks, the corneal epithelium was scraped off in all rats and its dulcitol content was determined by gas chromatography. CT-112 ophthalmic solution was found to inhibit the accumulation of dulcitol in a dose-dependent manner, except for the 1.0% solution which had an activity comparable to the 0.25% solution.
研究了醛糖还原酶抑制剂CT - 112(5 -(3 - 乙氧基 - 4 - 戊氧基苯基)- 2,4 - 噻唑烷二酮)滴眼液对喂食50%半乳糖饮食的大鼠角膜上皮中糖醇( Dulcitol)积累的抑制作用。这些作用与药物溶液的浓度相关。将大鼠分为6组。一组喂食常规实验室饲料且未接受治疗。其他5组喂食50%半乳糖饮食,在5个治疗组中,每组大鼠双眼每天滴注4次0.1%、0.25%、0.5%或1.0%的CT - 112滴眼液或其赋形剂。2周后,刮下所有大鼠的角膜上皮,通过气相色谱法测定其Dulcitol含量。发现CT - 112滴眼液以剂量依赖方式抑制Dulcitol的积累,但1.0%溶液的活性与0.25%溶液相当。